Skip to main content
Erschienen in: Breast Cancer 4/2015

01.07.2015 | Original Article

What we should know in mammography after reduction mammoplasty and mastopexy?

verfasst von: Hanna Kim, Bong Joo Kang, Sung Hun Kim, Hyeon Sook Kim, Eun Suk Cha

Erschienen in: Breast Cancer | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Reduction mammoplasty and mastopexy (breast lift surgery) are becoming increasingly common procedures. Knowledge of characteristic mammographic findings and imaging findings of breast cancer are important to interpret mammography in this population.

Methods

Patients undergoing a mammography examination between March 2006 and March 2012 were consecutively included. Seventy mammography examinations in 39 patients after reduction mammoplasty and 22 mammography examinations in 19 patients after mastopexy were reviewed and analyzed retrospectively. We compared the frequency of each characteristic mammographic finding between reduction mammoplasty and mastopexy. We also analyzed imaging findings of breast cancer in this population.

Results

The most frequent mammographic finding of the reduction mammoplasty was nipple elevation (84.3 %). Other findings included retraction of the lower breast (80 %), thickening of the skin (78.6 %), downward shifting of the glandular tissue (47.1 %), retroareolar fibrotic band (42.9 %), and areolar skin calcification or lipid cyst (35.7 %). The most frequent mammographic finding of mastopexy was thickening of the skin (72.7 %). Other mastopexy findings included elevation of nipple (68.2 %), areolar skin calcification or lipid cyst (36.4 %), retraction of lower position (31.8 %), and retroareolar fibrotic band (31.8 %). Downward shifting of glandular tissue and retraction of the lower portion have statistically lower frequency in mastopexy cases (P < 0.05). Two breast cancers were diagnosed in reduction mammoplasty cases. One was missed and one was detected but difficult to diagnose using mammography.

Conclusion

Although mammography alone is not sufficient for breast screening after reduction mammoplasty, it may be possible to use mammography for postoperative follow-up after mastopexy only. So, operators should recognize that after reduction mammoplasty it will be hard to detect early breast cancer.
Literatur
1.
Zurück zum Zitat Stevenson TR, Goldstein JA. TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg. 1993;92(2):228–33.PubMedCrossRef Stevenson TR, Goldstein JA. TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg. 1993;92(2):228–33.PubMedCrossRef
2.
Zurück zum Zitat Hayes MK, Gold RH, Bassett LW. Mammographic findings after the removal of breast implants. AJR Am J Roentgenol. 1993;160(3):487–90.PubMedCrossRef Hayes MK, Gold RH, Bassett LW. Mammographic findings after the removal of breast implants. AJR Am J Roentgenol. 1993;160(3):487–90.PubMedCrossRef
3.
Zurück zum Zitat Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef
4.
Zurück zum Zitat Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef
5.
Zurück zum Zitat Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef
6.
Zurück zum Zitat Uematsu T, Kasami M, Uchida Y. Soft-copy reading in digital mammography of microcalcifications: diagnostic performance of a 5-megapixel cathode ray tube monitor versus a 3-megapixel liquid crystal display monitor in a clinical setting. Acta Radiol. 2007;48(7):714–20.PubMedCrossRef Uematsu T, Kasami M, Uchida Y. Soft-copy reading in digital mammography of microcalcifications: diagnostic performance of a 5-megapixel cathode ray tube monitor versus a 3-megapixel liquid crystal display monitor in a clinical setting. Acta Radiol. 2007;48(7):714–20.PubMedCrossRef
7.
Zurück zum Zitat American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston: American College of Radiology, 2003. American College of Radiology. Breast imaging reporting and data system, breast imaging atlas. 4th ed. Reston: American College of Radiology, 2003.
8.
Zurück zum Zitat Miller CL, Feig SA, Fox JW. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef Miller CL, Feig SA, Fox JW. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef
9.
Zurück zum Zitat Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, et al. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms. Cancer Sci. 2011;102(10):1862–7.PubMedCrossRef Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, et al. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms. Cancer Sci. 2011;102(10):1862–7.PubMedCrossRef
10.
Zurück zum Zitat Lee JH, Kim EK, Oh JY, Kwon HC, Kim SH, Kim DC, et al. US screening for detection of nonpalpable locoregional recurrence after mastectomy. Eur J Radiol. 2013;82(3):485–9.PubMedCrossRef Lee JH, Kim EK, Oh JY, Kwon HC, Kim SH, Kim DC, et al. US screening for detection of nonpalpable locoregional recurrence after mastectomy. Eur J Radiol. 2013;82(3):485–9.PubMedCrossRef
11.
Zurück zum Zitat Abboud M, Vadoud-Seyedi J, De Mey A, Cukierfajn M, Lejour M. Incidence of calcifications in the breast after surgical reduction and liposuction. Plast Reconstr Surg. 1995;96(3):620–6.PubMedCrossRef Abboud M, Vadoud-Seyedi J, De Mey A, Cukierfajn M, Lejour M. Incidence of calcifications in the breast after surgical reduction and liposuction. Plast Reconstr Surg. 1995;96(3):620–6.PubMedCrossRef
12.
Zurück zum Zitat Robertson JL. Changed appearance of mammograms following breast reduction. Plast Reconstr Surg. 1977;59(3):347–51.PubMedCrossRef Robertson JL. Changed appearance of mammograms following breast reduction. Plast Reconstr Surg. 1977;59(3):347–51.PubMedCrossRef
13.
Zurück zum Zitat Mitnick JS, Roses DF, Harris MN, Colen SR. Calcifications of the breast after reduction mammoplasty. Surg Gynecol. 1990;171(5):409–12. Mitnick JS, Roses DF, Harris MN, Colen SR. Calcifications of the breast after reduction mammoplasty. Surg Gynecol. 1990;171(5):409–12.
14.
Zurück zum Zitat Sickles EA, Herzog KA. Mammography of the postsurgical breast. AJR Am J Roentgenol. 1981;136(3):585–8.PubMedCrossRef Sickles EA, Herzog KA. Mammography of the postsurgical breast. AJR Am J Roentgenol. 1981;136(3):585–8.PubMedCrossRef
15.
Zurück zum Zitat Mandrekas AD, Assimakopoulos GI, Mastorakos DP, Pantzalis K. Fat necrosis following breast reduction. Br J Plast Surg. 1994;47(8):560–2.PubMedCrossRef Mandrekas AD, Assimakopoulos GI, Mastorakos DP, Pantzalis K. Fat necrosis following breast reduction. Br J Plast Surg. 1994;47(8):560–2.PubMedCrossRef
16.
Zurück zum Zitat Miller JA, Festa S, Goldstein M. Benign fat necrosis simulating bilateral breast malignancy after reduction mammoplasty. South Med J. 1998;91(8):765–7.PubMedCrossRef Miller JA, Festa S, Goldstein M. Benign fat necrosis simulating bilateral breast malignancy after reduction mammoplasty. South Med J. 1998;91(8):765–7.PubMedCrossRef
17.
Zurück zum Zitat Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesthetic Plast Surg. 2001;25(4):283–5.PubMedCrossRef
18.
Zurück zum Zitat Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.PubMedCentralPubMedCrossRef Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539–44.PubMedCrossRef Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539–44.PubMedCrossRef
Metadaten
Titel
What we should know in mammography after reduction mammoplasty and mastopexy?
verfasst von
Hanna Kim
Bong Joo Kang
Sung Hun Kim
Hyeon Sook Kim
Eun Suk Cha
Publikationsdatum
01.07.2015
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 4/2015
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-013-0494-y

Weitere Artikel der Ausgabe 4/2015

Breast Cancer 4/2015 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.